R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

Veeva R&D and Quality 2024: Chris Moore

During the Veeva R&D and Quality Summit held in Madrid last month, web editor Nicole Raleigh sat down with Chris Moore, president of Europe for Veeva Systems, to discuss the event and i

R&D

The future of fertility and the vaginal microbiome

As societies have modernised, fertility rates have declined substantially.

R&D

Generative AI in clinical trials: Practical use cases and co...

With the hype around generative AI (GenAI), there is an increasing demand to explore its capabilities across pharma and MedTech companies, as well as contract research organisations.

R&D

The new genomic frontier: Next-generation data management ta...

Genomics is changing the world.

R&D

Neuroplastogens: A novel approach to treat neurological dise...

In the US alone, one in five adults experiences a form of mental illness each year. New medicines are urgently needed, as current therapies fail to work in up to a third of patients.

R&D